nephropathy

Original Contribution

Ioxaglate Versus IoDixanol for the Prevention of Contrast-induced Nephropathy: The IDPC Trial

05/16/2023

Rafaela Andrade Penalva Freitas, MD, PhD¹; Luis Fernando Tanajura, MD, PhD¹; Roxana Mehran, MD²; Daniel Chamié, MD, PhD¹; Aurea Chaves, MD, PhD¹; Marinella Centemero, MD, PhD¹; Sergio Braga, MD, PhD¹; Ricardo Costa, MD, PhD¹; Davide Cao²; Amanda Sousa, MD, PhD¹; Fausto Feres, MD, PhD¹; J. Ribamar Costa Jr, MD, PhD¹

Rafaela Andrade Penalva Freitas, MD, ...

Despite the potential benefits of percutaneous procedures for the assessment and treatment of coronary artery disease, these interventions require the use of iodine contrast, which might lead to contrast-induced nephropathy (CIN) and...

Despite the potential benefits...

05/16/2023

Journal of Invasive Cardiology